BlackRock’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$133M Buy
43,192,306
+4,325,527
+11% +$16.7M ﹤0.01% 1928
2025
Q4
$159M Buy
38,866,779
+7,127,014
+22% +$35.3M ﹤0.01% 1835
2025
Q3
$155M Buy
31,739,765
+3,368,702
+12% +$17.7M ﹤0.01% 1819
2025
Q2
$144M Buy
28,371,063
+4,864,474
+21% +$23.9M ﹤0.01% 1817
2025
Q1
$124M Buy
23,506,589
+69,953
+0.3% +$510K ﹤0.01% 1865
2024
Q4
$158M Buy
23,436,636
+2,693,839
+13% +$18.1M ﹤0.01% 1796
2024
Q3
$137M Buy
20,742,797
+3,432,635
+20% +$24.6M ﹤0.01% 1900
2024
Q2
$130M Buy
17,310,162
+4,989,127
+40% +$43.5M ﹤0.01% 1876
2024
Q1
$123M Sell
12,321,035
-72,837
-0.6% -$811K ﹤0.01% 1951
2023
Q4
$122M Buy
12,393,872
+536,918
+5% +$3.83M ﹤0.01% 1964
2023
Q3
$90.7M Buy
11,856,954
+237,527
+2% +$2.37M ﹤0.01% 2050
2023
Q2
$86.8M Buy
11,619,427
+987,570
+9% +$6.91M ﹤0.01% 2139
2023
Q1
$70.9M Sell
10,631,857
-35,767
-0.3% -$284K ﹤0.01% 2227
2022
Q4
$82.2M Buy
10,667,624
+900,584
+9% +$8.83M ﹤0.01% 2135
2022
Q3
$104M Buy
9,767,040
+1,525,258
+19% +$15.4M ﹤0.01% 1936
2022
Q2
$67.1M Buy
8,241,782
+1,534,025
+23% +$10.3M ﹤0.01% 2291
2022
Q1
$48M Sell
6,707,757
-54,927
-0.8% -$584K ﹤0.01% 2618
2021
Q4
$116M Buy
6,762,684
+4,995,020
+283% +$94M ﹤0.01% 2117
2021
Q3
$40.7M Buy
1,767,664
+323,586
+22% +$9.17M ﹤0.01% 2793
2021
Q2
$52.7M Buy
+1,444,078
New +$42.7M ﹤0.01% 2665

Other funds holding RXRX